Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 1979;2(3):285–310. doi: 10.1007/BF00198721

Antibody and complement-dependent viral neutralization

Neil R Cooper 1, Raymond M Welsh Jr 1
PMCID: PMC7087519  PMID: 32214620

The content is available as a PDF (2.0 MB).

References

  • 1.Almeida J. D., Laurence G. D. Heated and unheated antiserum on rubella virus. Am. J. Dis. Child. 1969;118:101. doi: 10.1001/archpedi.1969.02100040103017. [DOI] [PubMed] [Google Scholar]
  • 2.Almeida J. D., Waterson A. P. The morphology of virus-antibody interaction. Adv. Virus. Res. 1969;15:307. doi: 10.1016/S0065-3527(08)60878-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Apostolov K., Sawa M. I. Enhancement of haemolysis by Newcastle disease virus (NDV) after pretreatment with heterophile antibody and complement. J. Gen. Virol. 1976;33:459. doi: 10.1099/0022-1317-33-3-459. [DOI] [PubMed] [Google Scholar]
  • 4.Bartholomew R. M., Esser A. F. Differences in activation of human and guinea pig complement by retroviruses. J. Immunol. 1978;121:1748. [PubMed] [Google Scholar]
  • 5.Bartholomew R. M., Esser A. F., Müller-Eberhard H. J. Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E. J. Exp. Med. 1978;147:844. doi: 10.1084/jem.147.3.844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Berry D. M., Almeida J. D. The morphological and biological effects of various antisera on avian infectious bronchitis virus. J. Gen. Virol. 1968;3:97. doi: 10.1099/0022-1317-3-1-97. [DOI] [PubMed] [Google Scholar]
  • 7.Borsos T., Dourmashkin R. R., Humphrey J. H. Lesions in erythrocyte membranes caused by immune haemolysis. Nature. 1964;202:251. doi: 10.1038/202251a0. [DOI] [PubMed] [Google Scholar]
  • 8.Cooper N. R., Jensen F. C., Welsh R. M., Jr., Oldstone M. B. A. Lysis of RNA tumor viruses by human serum: Direct antibody independent triggering of the classical complement pathway. J. Exp. Med. 1976;144:970. doi: 10.1084/jem.144.4.970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Cooper N. R., Ziccardi R. J. The nature and reactions of complement enzymes. In: D. W. Brew K., editor. Proteolysis and physiological regulation; New York: Academic Press; 1976. p. 167. [Google Scholar]
  • 10.Daniels C. A. Mechanisms of virus neutralization. In: Notkins A. L., editor. Viral immunology and immunopathology. New York: Academic Press; 1975. p. 79. [Google Scholar]
  • 11.Daniels C. A., Borsos T., Rapp H. J., Snydermann R., Notkins A. L. Neutralization of sensitized virus by purified components of complement. Proc. Natl. Acad. Sci. USA. 1970;65:528. doi: 10.1073/pnas.65.3.528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Daniels C. A., Borsos T., Snyderman R., Notkins A. L. Neutralization of sensitized virus by the fourth component of complement. Science. 1969;165:508. doi: 10.1126/science.165.3892.508. [DOI] [PubMed] [Google Scholar]
  • 13.Fearon D. T., Austen K. F. The human complement system: Biochemistry, biology and pathobiology. Essays Med. Biochem. 1976;2:1. [Google Scholar]
  • 14.Frank M. M., May J., Gaither T., Ellman L. In vitro studies of complement function in sera of C4-deficient guinea pigs. J. Exp. Med. 1971;134:176. doi: 10.1084/jem.134.1.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Gallagher R. E., Gallo R. C. Type C RNA tumor virus isolated from cultured human acute myelogenous leukemia cells. Science. 1975;187:350. doi: 10.1126/science.46123. [DOI] [PubMed] [Google Scholar]
  • 16.Gallagher R. E., Schrecker A. W., Walter C. A., Gallo R. C. Oncornavirus lytic activity in the serum of gibbon apes. J. Natl. Cancer Inst. 1978;60:677. doi: 10.1093/jnci/60.3.677. [DOI] [PubMed] [Google Scholar]
  • 17.Gewurz H., Shin H. S., Mergenhagen S. E. Interactions of the complement system with endotoxic lipopolysaccharide: Consumption of each of the six terminal complement component. J. Exp. Med. 1968;128:1049. doi: 10.1084/jem.128.5.1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Ginsberg H. S., Horsfall F. L. A labile component of normal serum which combines with various viruses. Neutralization of infectivity and inhibition of hemagglutination by the component. J. Exp. Med. 1949;90:475. doi: 10.1084/jem.90.5.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Gordon M. H. Studies of the viruses of vaccinia and variola. London: Medical Research Council; 1925. [Google Scholar]
  • 20.Götze, O., Müller-Eberhard, H. J.: The C3-activator system: An alternate pathway of complement activation. J. Exp. Med. 134, 90s (1971) [PubMed]
  • 21.Götze O., Müller-Eberhard H. J. The alternative pathway of complement activation. Adv. Immunol. 1976;24:1. doi: 10.1016/s0065-2776(08)60328-4. [DOI] [PubMed] [Google Scholar]
  • 22.Haukenes G. Demonstration of host antigens in the myxovirus membrane: Lysis of virus by antibody and complement. Acta Pathol. Microbiol. Scand. [B] 1977;85:125. doi: 10.1111/j.1699-0463.1977.tb01685.x. [DOI] [PubMed] [Google Scholar]
  • 23.Hersch E. M., Hanna M. G., Jr., Gutterman J. U., Mavligit G., Yurconic M., Jr., Gschwind C. R. Human immune response to active immunization with Rauscher leukemia virus. II. Humoral immunity. J. Natl. Cancer Inst. 1974;53:327. doi: 10.1093/jnci/53.2.327. [DOI] [PubMed] [Google Scholar]
  • 24.Hugli T. E., Müller-Eberhard H. J. Anaphylatoxins: C3a and C5a. Adv. Immunol. 1978;26:1. doi: 10.1016/s0065-2776(08)60228-x. [DOI] [PubMed] [Google Scholar]
  • 25.Jensen F. C., Welsh R. M., Cooper N. R., Oldstone M. B.A. Lysis of oncornaviruses by human serum. Comp. Leukemia Res. Bibl. Haematol. 1976;43:438. doi: 10.1159/000399186. [DOI] [PubMed] [Google Scholar]
  • 26.Karshin W. L., Arcement L. J., Naso R. B., Arlinghaus R. B. Common precursor for Rauscher leukemia virus gp69/71, p15(E) and p12(E) J. Virol. 1977;23:787. doi: 10.1128/jvi.23.3.787-798.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kassel R. L., Hardy W. D., Jr., Day N. K. Complement in cancer. In: Day N. K., Good R. A., editors. Comprehensive immunology. Biological amplification systems in immunology. New York: Plenum Press; 1977. p. 277. [Google Scholar]
  • 28.Kassel R. L., Old L. J., Carswell E. A., Fiore N. C., Hardy W. D., Jr. Serum-mediated leukemia cell destruction in AKR mice. J. Exp. Med. 1973;138:925. doi: 10.1084/jem.138.4.925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Klenk H.-D., Rott R., Becht H. On the structure of the influenza virus envelope. Virology. 1972;47:579. doi: 10.1016/0042-6822(72)90547-8. [DOI] [PubMed] [Google Scholar]
  • 30.Laver W. G., Webster R. G. The structure of influenza viruses. IV. Chemical studies of the host antigen. Virology. 1966;30:104. doi: 10.1016/s0042-6822(66)81014-0. [DOI] [PubMed] [Google Scholar]
  • 31.Leddy J. P., Simons R. L., Douglas R. G. Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera. J. Immunol. 1977;118:28. [PubMed] [Google Scholar]
  • 32.Leong J. C., Kane J. P., Oleszko O., Levy J. A. Antigen-specific nonimmunoglobulin factor that neutralizes xenotropic virus is associated with mouse serum lipoproteins. Proc. Natl. Acad. Sci. USA. 1977;74:276. doi: 10.1073/pnas.74.1.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Linscott W. D., Levinson W. E. Complement components required for virus neutralization by early immunoglobulin antibody. Proc. Natl. Acad. Sci. USA. 1969;64:520. doi: 10.1073/pnas.64.2.520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Mandel B. Neutralization of poliovirus: A hypothesis to explain the mechanism and the one-hit character of the neutralization reaction. Virology. 1976;69:500. doi: 10.1016/0042-6822(76)90480-3. [DOI] [PubMed] [Google Scholar]
  • 35.Marcus R. L., Shin H. S., Mayer M. M. An alternate complement pathway: C-3 cleaving activity, not due to C4,2a, on endotoxic lipopolysaccharide after treatment with guinea pig serum; relation to properdin. Proc. Natl. Acad. Sci. USA. 1971;68:1351. doi: 10.1073/pnas.68.6.1351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Mills B. J., Cooper N. R. Analysis of the mechanism of VSV inactivation by human serum. J. Immunol. 1978;120:1786. [Google Scholar]
  • 37.Mills B. J., Cooper N. R. Antibody-independent neutralization of vesicular stomatitis virus by human complement. I. Complement requirements. J. Immunol. 1978;121:1594. [PubMed] [Google Scholar]
  • 38.Müller-Eberhard H. J. Complement. Annu. Rev. Biochem. 1975;44:697. doi: 10.1146/annurev.bi.44.070175.003405. [DOI] [PubMed] [Google Scholar]
  • 39.Notkins A. L., Rosenthal J., Johnson B. Rate-zanol centrifugation of herpes simplex virus-antibody complexes. Virology. 1971;43:321. doi: 10.1016/0042-6822(71)90253-4. [DOI] [PubMed] [Google Scholar]
  • 40.Ogra P. L., Morag A., Tiku M. L. Humoral immune response to viral infections. In: Notkins A. L., editor. Viral immunology and immunopathology. New York: Academic Press; 1975. p. 57. [Google Scholar]
  • 41.Oldstone M. B. A. Virus neutralization and virus-induced immune complex disease. Virus-antibody union resulting in immunoprotection or immunologic injury—two sides of the same coin. Prog. Med. Virol. 1975;19:84. [PubMed] [Google Scholar]
  • 42.Oldstone M. B. A., Lampert P. W. Antibody-mediated complement-dependent lysis of virus infected cells. Springer Semin. Immunopathol. 1979;2:261–283. doi: 10.1007/BF00198720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Oldstone M. B A., Cooper N. R., Larson D. L. Formation and biologic role of polyoma virus-antibody complexes. J. Exp. Med. 1974;140:549. doi: 10.1084/jem.140.2.549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Orozlan S., Gilden R. V. Immune virolysis: Effect of antibody and complement on C-type RNA virus. Science. 1970;168:1478. doi: 10.1126/science.168.3938.1478. [DOI] [PubMed] [Google Scholar]
  • 45.Osler A. G. Complement-Mechanisms and functions. Englewood Cliffs, New Jersey: Prentice-Hall; 1976. [Google Scholar]
  • 46.Osler A. G., Sandberg A. L. Alternate complement pathways. Prog. Allergy. 1973;17:51. [PubMed] [Google Scholar]
  • 47.Radwan A. I., Burger D., Davis W. C. The fate of sensitized equine arteritis virus following neutralization by complement or anti-IgG serum. Virology. 1973;53:372. doi: 10.1016/0042-6822(73)90216-x. [DOI] [PubMed] [Google Scholar]
  • 48.Radwan A. I., Crawford T. E. The mechanisms of neutralization of sensitized equine arteritis virus by complement components. J. Gen. Virol. 1974;25:229. doi: 10.1099/0022-1317-25-2-229. [DOI] [PubMed] [Google Scholar]
  • 49.Reid K. B. M., Porter R. R. The structure and mechanism of activation of the first component of complement. Contemp. Top. Mol. Immunol. 1975;4:1. doi: 10.1007/978-1-4615-8930-3_1. [DOI] [PubMed] [Google Scholar]
  • 50.Rosen F. S., Lachmann P. J. Genetic Defects of Complement in Man. Springer Sem. Immunopathol. 1978;1:339–353. [Google Scholar]
  • 51.Rott R., Drzeniek R., Saber M. S., Reichert E. Blood group substances, Forssman and mononucleosis antigens in lipid-containing RNA viruses. Arch. Ges. Virusforsch. 1966;19:273. [Google Scholar]
  • 52.Sandberg A. L., Osler A. G., Shin H. S., Oliveira B. The biologic activities of guinea pig antibodies. II. Modes of complement interaction with γ1 and γ2 immunoglobulins. J. Immunol. 1970;104:329. [PubMed] [Google Scholar]
  • 53.Schloemer R. H., Wagner R. R. Association of vesicular stomatitis virus glycoprotein with virion membranes: Characterization of lipophilic TPK fragment. J. Virol. 1975;16:237. doi: 10.1128/jvi.16.2.237-240.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Schluederberg A., Ajello C., Evans B. Fate of rubella genome ribonucleic acid after immune and nonimmune virolysis in the presence of ribonuclease. Infect. Immun. 1976;14:1097. doi: 10.1128/iai.14.4.1097-1102.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Schreiber R. D., Pangburn M. K., Lesavre P. H., Müller-Eberhard H. J. Initiation of the alternative pathway of complement: Recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins. Proc. Natl. Acad. Sci. USA. 1978;75:3948. doi: 10.1073/pnas.75.8.3948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Sherwin S. A., Benveniste R. E., Todaro G. J. Complement-mediated lysis of type-C virus: Effect of primate and human sera on various retroviruses. Int. J. Cancer. 1978;21:6. doi: 10.1002/ijc.2910210103. [DOI] [PubMed] [Google Scholar]
  • 57.Silverstein S. Macrophages and viral immunity. Semin. Hematol. 1970;7:185. [PubMed] [Google Scholar]
  • 58.Simpson R. W., Hauser R. E. Influence of lipids on the viral phenotype. I. Interactions of myxoviruses and their lipid constituents with phospholipases. Virology. 1966;30:684. doi: 10.1016/0042-6822(66)90173-5. [DOI] [PubMed] [Google Scholar]
  • 59.Stollar V. Immune lysis of Sindbis virus. Virology. 1975;66:620. doi: 10.1016/0042-6822(75)90235-4. [DOI] [PubMed] [Google Scholar]
  • 60.Svehag S.-E. Formation and dissociation of virus-antibody complexes with special reference to the neutralization process. Prog. Med. Virol. 1968;10:1. [PubMed] [Google Scholar]
  • 61.Thiry L., Clerc J. C.-L., Content J., Tack L. Factors which influence inactivation of vesicular stomatitis virus by fresh human serum. Virology. 1978;87:384. doi: 10.1016/0042-6822(78)90142-3. [DOI] [PubMed] [Google Scholar]
  • 62.Wallis C., Melnick J. L. Herpesvirus neutralization: The role of complement. J. Immunol. 1971;107:1235. [PubMed] [Google Scholar]
  • 63.Wedgwood R. J., Ginsberg H. S., Pillemer L. The properdin system and immunity. VI. The inactivation of Newcastle disease virus by the properdin system. J. Exp. Med. 1956;104:107. doi: 10.1084/jem.104.5.707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Welsh R. M., Jr. Host cell modification of lymphocytic chriomeningitis virus and Newcastle disease virus altering viral inactivation by human complement. J. Immunol. 1977;118:348. [PubMed] [Google Scholar]
  • 65.Welsh R. M., Jr., Cooper N. R., Jensen F. C., Oldstone M. B. A. Human serum lyses RNA tumor viruses. Nature. 1975;257:612. doi: 10.1038/257612a0. [DOI] [PubMed] [Google Scholar]
  • 66.Welsh R. M., Cooper N. R., Jensen F. C., Oldstone M.B.A. Inactivation and lysis of oncornaviruses by human serum. Virology. 1976;74:432. doi: 10.1016/0042-6822(76)90349-4. [DOI] [PubMed] [Google Scholar]
  • 67.Welsh R. M., Jr., Lampert P. W., Burner P. A., Oldstone M.B.A. Antibody-complement interactions with purified lymphocytic choriomeningitis virus. Virology. 1976;73:59. doi: 10.1016/0042-6822(76)90060-x. [DOI] [PubMed] [Google Scholar]
  • 68.Wilson G. S., Miles A. Topley and Wilson's principles of bacteriology, Virology, and immunity. 6th ed. Baltimore, Maryland: Williams and Wilkins Co.; 1975. p. 1438. [Google Scholar]
  • 69.Yoshino K., Taniguchi S. Effect of complement upon viral neutralization. J. Immunol. 1969;102:1341. [Google Scholar]

Articles from Springer Seminars in Immunopathology are provided here courtesy of Nature Publishing Group

RESOURCES